Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes - study in hypoxic alginate bead cultures

Osteoarthritis and Cartilage

Volumn 16, Issue 1, 2008, Pages 105-114

  Legendre, F ^a   Bauge C ^a   Roche, R ^b   Saurel, A S ^b   Pujol, J P ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

Author keywords

Chondrocytes; Chondroitin sulfate; Gene expression; Interleukin 1

Indexed keywords

AGGRECAN; AGGRECANASE; AGGRECANASE 1; AGGRECANASE 2; ALGINIC ACID; CHONDROITIN SULFATE; COLLAGENASE 3; CYCLOOXYGENASE 2; GLYCOSAMINOGLYCAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 1BETA; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; BIOSYNTHESIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; CHONDROCYTES; CHONDROITIN SULFATES; ENZYMES; GENE EXPRESSION; GLYCOSAMINOGLYCANS; INTERLEUKIN-1BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 38349193381     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.05.020     Document Type: Article

References (53)

1. 13C nuclear magnetic resonance identification and characterization of components of chondroitin sulfates of various origins. Carbohydr Polym 41 (2000) 37-45
2. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 62 (2005) 2241-2256
3. Ghosh P., and Smith M. Osteoarthritis, genetic and molecular mechanisms. Biogerontology 3 (2002) 85-88
4. Pipitone V.R. Chondroprotection with chondroitin sulfate. Drug Exp Clin Res 17 (1991) 3-7
5. Uebelhart D., and Chantraine A. Efficacité clinique du sulfate de chondroïtine dans la gonarthrose: étude randomisée en double-insu versus placebo. Rev Rhum 10 (1994) 692
6. Morreale P., Manopoulo R., Galati M., Boccanera L., Saponati G., and Bocchi L. Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 23 (1996) 1385-1391
7. Uebelhart D., Thonar E., Delmas P.D., Chantraine A., and Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 6 Suppl A (1998) 39-46
8. Bourgeois P., Chales G., Dehais J., Delcambre B., Kunz L.-L., and Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo. Osteoarthritis Cartilage 6 Suppl A (1998) 25-30
9. Bucsi L., and Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 6 Suppl A (1998) 31-36
10. Bassleer C.T., Combal J.P.A., Bougaret S., and Malaise M. Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 6 (1998) 196-204
11. Ronca F., Palmieri L., Panicucci P., and Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6 (1998) 14-21
12. Chan P.S., Caron J.P., and Orth M.W. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 66 (2005) 1870-1876
13. 2 in articular cartilage explants. Osteoarthritis Cartilage 13 (2005) 387-394
14. Häuselmann H.J., Aydelotte M.B., Schumacher B.L., Kuettner K.E., Gitelis S.H., and Thonar E.J.M.A. Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix 12 (1992) 116-129
15. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
16. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25 (2001) 402-408
17. Kavalkovich K.W., Boynton R.E., Murphy J.M., and Barry F. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. Cell Dev Biol 38 (2002) 457-466
18. Bjornsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 210 (1993) 282-291
19. Blanco F.J., Ochs R.L., Schwarz H., and Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146 (1995) 75-85
20. Chadjichristos C., Ghayor C., Kypriotou M., Martin G., Renard E., Ala-Kokko L., et al. Sp3 and Sp1 transcription factors mediate interleukin-1β down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem 278 (2003) 39762-39772
21. Benton H.P., and Tyler J.A. Inhibition of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 154 (1988) 421-428
22. Rédini F., Mauviel A., Pronost S., Loyau G., and Pujol J.P. Transforming growth factor β exerts opposite effects from interleukin-1β on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 36 (1993) 44-50
23. Boumediene K., Conrozier T., Mathieu P., Richard M., Marcelli C., Vignon E., et al. Decrease of cartilage transforming growth factor-β receptor II expression in the rabbit experimental osteoarthritis-potential role in cartilage breakdown. Osteoarthritis Cartilage 6 (1998) 146-149
24. Serra R., Johnson M., Filvaroff E.H., Laborde J., Sheehan D.M., Derynck R., et al. Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissues promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139 (1997) 541-552
25. Pujol J.P. TGF-β and osteoarthritis: in vivo veritas?. Osteoarthritis Cartilage 7 (1999) 439-440
26. Benya P.D., Padilla S.R., and Nimni M.E. The progeny of rabbit articular chondrocytes synthesize collagen type I and III and type I trimer, but not type II. Verification by cyanogen bromide peptide analysis. Biochemistry 16 (1977) 865-872
27. Silver I.A. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 271 (1975) 261-272
28. Fosang A.J., Last K., and Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 98 (1996) 2292-2299
29. Zafarullah M., Pelletier J.P., Cloutier J.M., and Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatol 20 (1993) 693-697
30. Nguyen Q., Mort J.S., and Roughley P.J. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 89 (1992) 1189-1197
31. Chubinskaya S., Kuettner K.E., and Cole A.A. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 79 (1999) 1669-1677
32. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99 (1997) 1534-1545
33. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., and Partel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 97 (1996) 2011-2019
34. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A., Chubinskaya S., and Hasty K.A. Osteoarthritis lesions: involvement of three different collagenases. Arthritis Rheum 40 (1997) 2065-2074
35. Liacini A., Sylvester J., Li W.Q., and Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulate matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21 (2002) 251-262
36. Monfort J., Nacher M., Montell E., Vila J., Verges J., and Benito P. Chondroitin sulfate and hyaluronic acid (500-730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drug Exp Clin Res 31 (2005) 71-76
37. Homandberg G.A., Guo D., Ray L.M., and Ding L. Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone. Osteoarthritis Cartilage 14 (2006) 793-806
38. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., and Lohmander L.S. Human osteoarthritic synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 14 (2006) 101-113
39. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434 (2005) 644-648
40. Sandy J.D. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14 (2006) 95-100
41. Hayashi T., Abe E., Yamate T., Taguchi Y., and Jasin H.E. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 40 (1997) 261-269
42. Oh M., Fukuda K., Asada S., Yasuda Y., and Tanaka S. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxinitrite. J Rheumatol 25 (1998) 2169-2174
43. Tiku M.L., Gupta S., and Desmukh D.R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 30 (1999) 395-405
44. Lyons C.R., Orloff G.J., and Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267 (1992) 6370-6374
45. Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di Silvio M., Wang S.C., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90 (1993) 3491-3495
46. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., et al. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 275 (2000) 26040-26049
47. Vuolteenaho K., Moilanen T., Jalonen U., Lahti A., Nieminen R., van Beuningen H.M., et al. TGFbeta inhibits IL-1-induced iNOS expression and NO production in immortalized chondrocytes. Inflamm Res 54 (2005) 420-427
48. Pelletier J.P., Fernandes J.C., Jovanovic D.V., Reboul P., and Martel-Pelletier J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol 28 (2001) 2509-2519
49. Berenbaum F., Jacques C., Thomas G., Corvol M.T., Bereziat G., Masliah J., et al. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. Exp Cell Res 22 (1996) 379-384
50. Neil K.M., Orth M.W., Coussens P.M., Chan P.S., and Caron J.P. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultures equine chondrocytes stimulated by use of recombinant equine interleukin-1 beta. Am J Vet Res 66 (2005) 1861-1869
51. Lippiello L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under stimulated conditions of joint stress. Osteoarthritis Cartilage 11 (2003) 335-342
52. Sevalla K., Todhunter R.J., Vernier-Singer M., and Budsberg S.C. Effect of polysulfated glycosaminoglycan on DNA content and proteoglycan metabolism in normal and osteoarthritis canine articular cartilage explants. Vet Surg 29 (2000) 407-414
53. Heraud F., Burger F., Rebuffet E., Amigues S., Soler C., and Imberty A. Bovine, porcine and ichthyic chondroitin sulfate decrease IL-1beta effects on NO production and apoptosis: correlation with molecular modeling data. Osteoarthritis Cartilage 14 Suppl B (2006) P192